ClinicalTrials.gg
TerminatedNCT06289556Updated Aug 25, 2026Results posted

Clinical Performance of Masimo INVSENSOR00048

An interventional study of Masimo INVSENSOR00048 in Fever and Healthy, sponsored by Masimo Corporation. Terminated at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-08-25.

Sponsored by Masimo Corporation (part of Danaher Corporation) · Interventional and Other

Why this study was terminated
Sponsor Decision
Study type
Interventional
Enrollment
180
Allocation
Not applicable
Sex
All
01

Study summary

The objective of this clinical study is to validate temperature performance of the noninvasive Masimo INVSENSOR00048.

02

Conditions studied

  • Fever
  • Healthy

Browse trials for

03

In context

Fever

438 studies on the registry are indexed under Fever; 55 are open to participants now.

This study's enrollment of 180 is above the median of 123 across 271 interventional studies indexed under Fever.

Browse Fever studies →

Lead sponsor

Masimo Corporation is the lead sponsor of 105 studies on the registry; 1 is open to participants now.

Of its 79 completed or terminated interventional studies of FDA-regulated products, 66 (84%) have results posted.

First submitted before Masimo Corporation became part of Danaher Corporation.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Afebrile subjects of all ages, or febrile subjects of all ages who meet the following criteria for screening temperature:
  • sublingual temperature ≥ 37.5°C (99.5°F),
  • rectal temperature ≥ 38.0°C (100.4°F),
  • or axillary temperature ≥ 37.2°C (99.0°F)
  • If subject is \< 18 years old, parents or legally authorized representatives (LAR) have provided and have signed all necessary related documents

Exclusion criteria

Exclusion Criteria:

  • Subjects with medical conditions such as inflammation at the measuring site or taking medications e.g. barbiturates, thyroid preparations, antipsychotics, or immunization within prior 7 days, which might skew clinical accuracy validation results such as, per the investigator's judgement
  • Subjects unable to provide or assent, as appropriate
  • Subjects with conditions at or around site of sensor placement or skin abnormalities affecting the sensor placement area such as psoriasis, eczema, angioma, scar tissue, burn, fungal infection, substantial skin breakdown that would prevent monitoring of physiological parameters during the study
  • Subjects with known allergies to adhesive material used in medical equipment
  • Subjects with medical conditions which, in the judgment of the investigator, renders them inappropriate for participation in this study
  • Excluded at the Principal Investigator's discretion
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Primary purpose
Other
Allocation
Not applicable
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
180 participants (actual)

Study arms

  • Experimental
    INVSENSOR00048

    All subjects are enrolled into this arm and will have temperature measurements obtained.

    Device: Masimo INVSENSOR00048

Interventions

  • DeviceMasimo INVSENSOR00048

    Masimo INVSENSOR00048 will be used to collect temperature measurements.

06

What researchers measure

Primary outcomes

  1. Clinical Performance of Masimo INVSENSOR00048

    The outcome measure is determination of the Masimo INVSENSOR00048 temperature performance by comparing the Clinical Bias and Limits of Agreement (LOA) between the corresponding adjustment mode temperature of the INVSENSOR00048 and reference thermometer in degrees celsius. Clincal Bias is defined as mean difference between output temperatires of a clinical thermometer and a reference clinical thermometer for the intended reference body site with specified limitis of agreement when measured from selected group of subjects . Limits of agreement is defined as the magnitude of a potential disagreement between outputs of two clinical thermometers equal to double the standard deviation of output temperate differences when used on the same human subject .

    Time frame: Approximately 90 minutes

07

Results

Posted Aug 25, 2026

Participant flow

Participant flow — Overall Study
MilestoneINVSENSOR00048
Started180
Completed109
Not completed71
Withdrew: Withdrawal by subject3
Withdrew: Data transfer failure12
Withdrew: Met data exclusion criteria56

Outcome measures

PrimaryClinical Performance of Masimo INVSENSOR00048

The outcome measure is determination of the Masimo INVSENSOR00048 temperature performance by comparing the Clinical Bias and Limits of Agreement (LOA) between the corresponding adjustment mode temperature of the INVSENSOR00048 and reference thermometer in degrees celsius. Clincal Bias is defined as mean difference between output temperatires of a clinical thermometer and a reference clinical thermometer for the intended reference body site with specified limitis of agreement when measured from selected group of subjects . Limits of agreement is defined as the magnitude of a potential disagreement between outputs of two clinical thermometers equal to double the standard deviation of output temperate differences when used on the same human subject .

Time frame:
Approximately 90 minutes
Reported as:
Number · Degrees Celsius
Clinical Performance of Masimo INVSENSOR00048
Degrees CelsiusINVSENSOR00048
Clinical Bias0.19
Limits of Agreement0.76

Adverse events

Collected over 1-5 hours. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
INVSENSOR000480/180 (0%)0/180 (0%)1/180 (0.6%)
Most frequent other events
Most frequent other events
EventINVSENSOR00048
Itchiness and redness at device placement siteInjury, poisoning and procedural complications1/180

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)INVSENSOR00048
<=18 years109
Between 18 and 65 years0
>=65 years0
Sex: Female, Male
Sex: Female, Male(Participants)INVSENSOR00048
Female71
Male38
Race (NIH/OMB)
Race (NIH/OMB)(Participants)INVSENSOR00048
American Indian or Alaska Native1
Asian10
Native Hawaiian or Other Pacific Islander2
Black or African American4
White66
More than one race5
Unknown or Not Reported21
08

Study locations

1 site
  • Children's Hospital of Orange County
    Orange, California 92868, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06289556
Lead sponsor
Masimo Corporation
Responsible party
Sponsor
First posted
Mar 4, 2024
Start date
Jan 23, 2024
Primary completion
May 19, 2025
Completion
May 19, 2025
Results posted
Aug 25, 2026
Last update
Aug 25, 2026

Oversight

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion